Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535248 · ClinicalTrials.gov registry record
Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 17
- Enrollment target
NCT01535248 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 17 participants.
The verdict
NCT01535248 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopy technique to visualize and evaluate the pancreatic and biliary systems. It has been reported that rare instances of air embolus have been found associated with the performance of an ERCP and many of these events are fatal. It is our proposal to use transthoracic echocardiography to continuously evaluate for the presence of intra-cardiac air secondary to ERCP venous air embolism and attempt to quantify the incidence of this complication and any potential patient factors that might increase the risk of this complication.
Interventions
- OTHER Transthoracic Echocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-03-07 |
| Est. Completion | 2015-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01535248
The ClinicalTrials.gov registry entry for NCT01535248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transthoracic Echocardiography is the first listed.
NCT01535248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01535248 about?
NCT01535248 is a clinical study titled "Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus". Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopy technique to visualize and evaluate the pancreatic and biliary systems. It has been reported that rare instances of air embolus have been found associated with the performance of an ERCP and many of these events are fatal. It is o...
What is the current status of trial NCT01535248?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2012-03-07. Estimated completion is 2015-12-30.
What interventions are being tested in trial NCT01535248?
The interventions under investigation include: Transthoracic Echocardiography (OTHER).
Who is sponsoring clinical trial NCT01535248?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.